DONGHEE KANG

Prof. DONGHEE KANG

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Korean Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
DKDONGHEE KANG
DONGHEE KANG
CLChangwoo Lim
Changwoo Lim
DSDong-Jin Shim
Dong-Jin Shim
HKHuiyoung Kim
Huiyoung Kim
JKJi-Wook Kim
Ji-Wook Kim
SRSie Jeong Ryu
Sie Jeong Ryu
Sedation by dexmedetomidine, like natural sleep, often causes bradycardia. We explored the nature of heart rate (HR) changes as they occur during natural sleep versus those occurring during dexmedetomidine sedation. The present study included 30 patients who were scheduled to undergo elective surgery with spinal anesthesia. To assess HR and sedation, a pulse oximeter and bispectral index (BIS) monitor were attached to the patient in the ward and the operating room. After measuring HR and BIS at baseline, as the patients slept and once their BIS was below 70, HR and BIS were measured at 5-minute intervals during sleep. Baseline HR and BIS were also recorded before spinal anesthesia measured at 5-minute intervals after dexmedetomidine injection. During natural sleep, HR changes ranged from 2 to 19 beats/min (13.4 ± 4.4 beats/min), while in dexmedetomidine sedation, HR ranged from 9 to 40 beats/min (25.4 ± 8.5 beats/min). Decrease in HR was significantly correlated between natural sleep and dexmedetomidine sedation (R2 = 0.41, P < 0.001). The lowest HR was reached in 66 min during natural sleep (59 beats/min) and in 13 min with dexmedetomidine sedation (55 beats/min). The time to reach minimum HR was significantly different (P < 0.001), but there was no difference in the lowest HR obtained (P = 0.09). There was a correlation between the change in HR during natural sleep and dexmedetomidine sedation. The bradycardia that occurs when using dexmedetomidine may be a normal physiologic change, that can be monitored rather than corrected.

20 May 2003 in Bulletin of the Korean Chemical Society
Verified
Journal Article
Open access
KKKyung Soo Kim
Kyung Soo Kim
HJHancheol Jeong
Hancheol Jeong
JCJungyoung Cho
Jungyoung Cho
DKDONGHEE KANG
DONGHEE KANG
HKHong Ki Kim
Hong Ki Kim
ISIlwun Shim
Ilwun Shim

13 October 2022 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
MYMinsu Yun
Minsu Yun
SPSun‐Hee Park
Sun‐Hee Park
DKDONGHEE KANG
DONGHEE KANG
JKJi Wook Kim
Ji Wook Kim
JKJu Deok Kim
Ju Deok Kim
Kyoung Seob SongKyoung Seob Song
Kyoung Seob Song
Although the physiological function of receptor‐interacting protein kinase (RIPK) 3 has emerged as a critical mediator of programmed necrosis/necroptosis, the intracellular role it plays as an attenuator in human lungs and human bronchial epithelia remains unclear. Here, we show that the expression of RIPK3 dramatically decreased in the inflamed tissues of human lungs, and moved from the nucleus to the cytoplasm. The overexpression of RIPK3 dramatically increased F‐actin formation and decreased the expression of genes for pro‐inflammatory cytokines (IL‐6 and IL‐1β), but not siRNA‐RIPK3. Interestingly, whereas RIPK3 was bound to histone 1b without LPS stimulation, the interaction between them was disrupted after 15 min of LPS treatment. Histone methylation could not maintain the binding of RIPK3 and activated movement towards the cytoplasm. In the cytoplasm, overexpressed RIPK3 continuously attenuated pro‐inflammatory cytokine gene expression by inhibiting NF‐κB activation, preventing the progression of inflammation during Pseudomonas aeruginosa infection. Our data indicated that RIPK3 is critical for the regulation of the LPS‐induced inflammatory microenvironment. Therefore, we suggest that RIPK3 is a potential therapeutic candidate for bacterial infection‐induced pulmonary inflammation.

30 October 2020 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
JKJiwook Kim
Jiwook Kim
DKDONGHEE KANG
DONGHEE KANG
HLHochul Lee
Hochul Lee
SRSungwon Ryu
Sungwon Ryu
SRSiejeong Ryu
Siejeong Ryu
DKDoosik Kim
Doosik Kim
Background: There are several advantages of low flow anesthesia including safety, economics, and eco-friendliness. However, oxygen concentration of fresh gas flow and inspired gas are large different in low flow anesthesia. This is a hurdle to access to low flow anesthesia. In this study, we aimed to investigate the change in inhaled oxygen concentration in low flow anesthesia using oxygen and medical air.Methods: A total of 60 patients scheduled for elective surgery with an American Society of Anesthesiologist physical status I or II were enrolled and randomly allocated into two groups. Group H: Fresh gas flow rate (FGF) 4 L/min (FiO₂ 0.5). Group L: FGF 1 L/min (FiO₂ 0.5). FGF was applied 4 L/min in initial phase (10 min) after intubation. After initial phase FGF was adjusted according to groups. FGF continued at the end of surgery. Oxygen and inhalation anesthetic gas concentration were recorded for 180 min at 15 min interval.Results: The inspired oxygen concentration decreased by 5.5% during the first 15 min in the group L. Inspired oxygen decreased by 1.5% during next 15 min. Inspired oxygen decreased by 1.4% for 30 to 60 min. The inspired oxygen of group L is 35.4 ± 4.0% in 180 min. The group H had little difference in inspired oxygen concentration over time and decreased by 1.8% for 180 min.Conclusions: The inspired oxygen concentration is maintained at 30% or more for 180 min in patients under 90 kg. Despite some technical difficulties, low flow anesthesia may be considered.

26 September 2023 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
HSHan Seo
Han Seo
HLHyun-Chae Lee
Hyun-Chae Lee
KLKi Chul Lee
Ki Chul Lee
DKDoosik Kim
Doosik Kim
JKJiwook Kim
Jiwook Kim
Kyoung Seob SongKyoung Seob Song
Kyoung Seob Song
Han Seo, Hyun-Chae Lee, Ki Chul Lee, Doosik Kim, Jiwook Kim, Donghee Kang, Hyung-Joo Chung, Hee-Jae Cha, Jeongtae Kim, and Kyoung Seob Song. Mol. Cells 2023;46:700-9. https://doi.org/10.14348/molcells.2023.0107

30 April 2020 in Anesthesia and Pain Medicine
Verified
Journal Article
Open access
YSYusom Shin
Yusom Shin
TPTae Woo Park
Tae Woo Park
HKHuiyoung Kim
Huiyoung Kim
DSDong-Jin Shim
Dong-Jin Shim
HLHochul Lee
Hochul Lee
DKDONGHEE KANG
DONGHEE KANG
Background: Postoperative pain is affected by preoperative depression. If the risk of postoperative pain associated with depression can be predicted preoperatively, anesthesiologists and/or surgeons can better manage it with personalized care. The objective of this study was to determine the efficacy of Patient Health Questionnaire-2 (PHQ-2) depression screening tool as a predictor of postoperative pain. Methods: A total of 50 patients scheduled for elective laparoscopic cholecystectomy with an American Society of Anesthesiologists grade of 1 or 2 were enrolled. They answered the PHQ-2, which consists of two questions, under the supervision of a researcher on the day before the surgery. The numerical rating scale (NRS) scores were assessed at post-anesthesia care unit (PACU), at 24, and 48 postoperative hours, and the amount of intravenous patient-controlled analgesia (IV-PCA) administered was documented at 24, 48, and 72 postoperative hours. At 72 h, the IV-PCA device was removed and the final dosage was recorded.Results: The NRS score in PACU was not significantly associated with the PHQ-2 score (correlation coefficients: 0.13 [P = 0.367]). However, the use of analgesics after surgery was higher in patients with PHQ-2 score of 3 or more (correlation coefficients: 0.33 [P = 0.018]).Conclusions: We observed a correlation between the PHQ-2 score and postoperative pain. Therefore, PHQ-2 could be useful as a screening test for preoperative depression. Particularly, when 3 points were used as the cut-off score, the PHQ-2 score was associated with the dosage of analgesics, and the analgesic demand could be expected to be high with higher PHQ-2 scores.